Allegheny Health Network said its COVID-19 vaccination campaign will include a third dose of the Moderna shot and a second dose of the Johnson & Johnson shot.

The announcement Monday follows last week’s federal emergency use authorization allowing the use of the vaccinations as boosters.

As a result, AHN said its clinicians “will continue to administer booster shots across western Pennsylvania to these newly-eligible patients.”

The eligible groups include anyone over 65, people 18-64 with underlying health conditions, and “those who are at increased risk of COVID-19 transmission from their occupation or residence in long-term care facilities.”

Advertise with us

A booster will not be administered until at least six months have passed from a patient’s second vaccine dose of the Moderna or Pfizer-BioNTech shots and at least two months from their initial J&J vaccine.

On Friday, tens of millions of Americans were green-lighted to receive booster doses of the Moderna and J&J vaccines after they were endorsed by Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention. Her endorsement came after receiving recommendations from expert advisers that the shots are safe and effective at bolstering protection against the coronavirus.

The endorsement means that nearly 100 million Americans at risk of severe disease can choose any of the three boosters now authorized in the United States, regardless of their original shot.

AHN said anyone wishing to schedule an appointment for their booster shot may do so by visiting the network’s online scheduling portal at ahn.org/coronavirus/vaccine/schedule, contacting their primary care physician or reaching out to their local pharmacy.

CDC’s sign-off on the additional boosters as well as the flexibility to mix and match the shots gives greater leeway to consumers, as well as to clinicians and pharmacies administering them to vulnerable populations. Health officials have repeatedly sought ways to make it easier for people to get another dose, especially those who have had side effects from one brand, or who worry about risks associated with a particular shot.

Advertise with us

The availability of boosters will be particularly welcome to the 15 million recipients of the Johnson & Johnson vaccine, many of whom have been particularly fearful of breakthrough infections given that shot’s lower level of protection compared with the messenger RNA vaccines.

“I agree that those who received a [Johnson & Johnson] vaccine should receive a second dose — I would prefer that those individuals get an mRNA vaccine” rather than a second Johnson & Johnson shot, said panel member Dr. Pablo J. Sanchez, a pediatrician at Ohio State University.

Interchangeability of shots is also likely to speed booster vaccination in nursing homes and other institutional settings where residents received different shots during the early rollout. The Pfizer-BioNTech booster is already in use since it was authorized and recommended last month.

For people who develop the rare side effect of myocarditis after vaccination with Moderna or Pfizer, and who are eligible for boosters, the advisers and the CDC recommend deferring the shot at least until symptoms have completely resolved.

About 105 million of fully vaccinated people have received the two-shot Pfizer series, according to the CDC. About 70 million of fully vaccinated people have received the Moderna shots. Only 15 million Americans were vaccinated with Johnson & Johnson shots, which arrived later and were delayed by an investigation of a rare adverse event, as well as a manufacturing problem.

Advertise with us

More than 11 million people have received a booster or an additional dose of a vaccine so far.

The Washington Post contributed.